Leuze ILVS9/4.8 Lichtleiterverstärker 11-30V DC Lichtleiterverstärker Terminalmodule Manufacturer number: BES516-371-E4-C

Name: Leuze ILVS9/4.8 Lichtleiterverstärker 11-30V DC Lichtleiterverstärker Terminalmodule Manufacturer number: BES516-371-E4-C
Brand: optinovo.com
SKU: 11264297986
Price: 119.00 USD
Availability: InStock
Rating: 4.3654 (26 reviews)

EUR119.00 EUR156.00

SKU 11264297986 · ★ 4.4

Leuze ILVS9/4.8 Lichtleiterverstärker 11-30V DC Lichtleiterverstärker Terminalmodule Manufacturer number: BES516-371-E4-C

EUR119.00

EUR156.00

SKU 11264297986 · ★ 4.4

Pay in 4 interest-free payments of $29.75 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 4 - Nov 9

Harbor notes

Description

Leuze ILVS9 4.8 Lichtleiterverstärker 11 30V DC Lichtleiterverstärker Terminalmodule Manufacturer number: BES516 371 E4 C Manufacturer number: BES516 371 E4 C Manufacturer: MTL 8 Zustand Neu Hinweis zur Kompatibilität Anschlusszubehör oder weitere Komponenten sind nicht enthalten

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for Leuze ILVS9/4.8 Lichtleiterverstärker 11-30V DC Lichtleiterverstärker Terminalmodule Manufacturer number: BES516-371-E4-C

What should I check when an offer includes something at no extra charge?

Consider the value of the main purchase independently of the extra. Look for any restriction on sharing or transferring the benefit when relevant.

How can I keep a support request clear when several people respond?

Do not resend sensitive information simply because a new person replies. Refer to previously supplied evidence when it remains relevant.

What should I do if I may have placed the same order twice?

Do not treat an acknowledgment of your inquiry as a completed cancellation. Follow confirmed instructions rather than assuming the same remedy applies at every stage.